Jacob van Naarden, Chief Business Officer at Loxo Oncology, Inc. (LOXO), sold 4,523 shares at $179.00 ($804K) on 2018-06-20, disclosed to the SEC on 2018-06-21.
Open-market sale of $804k LOXO by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $176.44 | 865 | $153K | 19.0% |
| 2 | $176.44 | 865 | $153K | 19.0% |
| 3 | $177.47 | 576 | $102K | 12.7% |
| 4 | $177.47 | 576 | $102K | 12.7% |
| 5 | $178.23 | 100 | $18K | 2.2% |
| 6 | $179.00 | 1,141 |
| $204K |
| 25.4% |
| 7 | $179.76 | 200 | $36K | 4.5% |
| 8 | $180.90 | 200 | $36K | 4.5% |
| Total | $177.73 avg | 4,523 | $804K | 100% |
| Filing → |
| LOXO | SELL | 2018-11-28 | $1.5M | — | Filing → |
| LOXO | SELL | 2018-10-05 | $2.0M | — | Filing → |
| LOXO | SELL | 2018-09-14 | $2.8M | — | Filing → |